• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].

作者信息

Gebuhr P H, Wilbek H, Soelberg M

机构信息

Ortopaedkirurgisk afdeling, Hvidovre Hospital.

出版信息

Ugeskr Laeger. 1996 Feb 19;158(8):1076-8.

PMID:8638341
Abstract

The effect of one week of treatment with naproxen on the formation of heterotopic ossification after cemented total hip arthroplasty was studied in a prospective trial. Twenty-seven patients received 500 mg naproxen twice daily for seven days postoperatively. The medication was started on the morning of the operation. The results were compared to a control group of 23 patients from a previous study who had not received any kind of nonsteroidal anti-inflammatory drug. All radiographs were randomly mixed and patient identification was blinded. Three months after the operation 12/23 patients in the control group and 3/27 in the naproxen-treated group had developed heterotopic ossification. One year after the operation 4/27 in the naproxen-treated group and 12/23 in the control group had heterotopic ossification (p < 0.05). Three patients in the control group and none in the naproxen-treated group developed severe ossification. It is concluded that naproxen given for one week can decrease the incidence of heterotopic ossification after total hip arthroplasty.

摘要

相似文献

1
[Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
Ugeskr Laeger. 1996 Feb 19;158(8):1076-8.
2
Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
Clin Orthop Relat Res. 1995 May(314):166-9.
3
Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients.
Acta Orthop Scand. 1991 Jun;62(3):226-9. doi: 10.3109/17453679108993597.
4
Naproxen in the prevention of heterotopic ossification after total hip replacement.萘普生在全髋关节置换术后预防异位骨化中的应用
Clin Orthop Relat Res. 1999 Dec(369):279-88. doi: 10.1097/00003086-199912000-00029.
5
Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis.萘普生预防髋关节手术后异位骨化的疗效:一项荟萃分析。
J Orthop Surg Res. 2018 Mar 5;13(1):48. doi: 10.1186/s13018-018-0747-8.
6
Preoperative irradiation for prevention of heterotopic ossification following total hip arthroplasty.全髋关节置换术后预防异位骨化的术前放射治疗。
J Bone Joint Surg Am. 1996 Jun;78(6):870-81. doi: 10.2106/00004623-199606000-00010.
7
Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field.全髋关节置换术后照射预防异位骨化。对有限区域给予单次800厘戈瑞的放射治疗。
J Bone Joint Surg Am. 1992 Feb;74(2):186-200.
8
Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.非甾体类抗炎药预防全髋关节置换术后异位骨化
Semin Arthroplasty. 1992 Jul;3(3):172-7.
9
The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty.
J Bone Joint Surg Am. 1986 Dec;68(9):1423-30.
10
Prevention of heterotopic ossification by nonsteroid antiinflammatory drugs after total hip arthroplasty.
Clin Orthop Relat Res. 1988 Dec(237):158-63.